Andrés Cadena

Statistics

Publications

Citations

3.9K

H-Index

Active since

2019

Affiliations

Hamilton Health Sciences(Current)

Instituto Dante Pazzanese de Cardiologia

Karolinska Institutet

Université Laval

Memphis VA Medical Center

Andrés Cadena is an author at Hamilton Health Sciences specializing in medicine, type 2 diabetes mellitus treatment, and type 2 diabetes pharmacotherapy.

Publications per year

2019–2020

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Roxadustat for CKD-related Anemia in Non-dialysis Patients

Daniel W. Coyne, Simon D. Roger, Sug Kyun Shin et al. · Kidney International Reports · 2020 · 114 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Stiffness, pain, and joint counts in chronic chikungunya disease: relevance to disability and quality of life

Hugh Watson, Sarah R. Tritsch, Liliana Encinales et al. · Clinical Rheumatology · 2020 · 79 citations · Full text

Medicine, Clinical Sciences, Neurology +14

Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms

Sarah R. Tritsch, Liliana Encinales, Nelly Pacheco et al. · The Journal of Rheumatology · 2019 · 73 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

1–5 of 5